Viewing Study NCT06498518


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2025-12-26 @ 4:06 AM
Study NCT ID: NCT06498518
Status: WITHDRAWN
Last Update Posted: 2025-07-11
First Post: 2024-07-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer
Sponsor: Karen Carty
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module